EUVIMEDEUVIMED entdecken
Crossref

Standardized production of hPSC-derived cardiomyocyte aggregates in stirred spinner flasks

Nils Kriedemann iD, Wiebke Triebert, Jana Teske, Mira Mertens, Annika Franke, Kevin Ullmann iD, Felix Manstein iD, Lika Drakhlis iD, Alexandra Haase iD, Caroline Halloin, Ulrich Martin iD, Robert Zweigerdt iD

Nature Protocols · 2024

DOI: 10.1038/s41596-024-00976-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nature Protocols, 2024. Verfasst von Nils Kriedemann und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic, Transplantation and Vascular Surgery (HTTG), Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEB…. Hauptthemen laut MEDLINE: Cell Culture Techniques, Cell Differentiation, Myocytes, Cardiac, Pluripotent Stem Cells. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft (German Research Foundation), Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research), Niedersächsische Ministerium für Wissenschaft und Kultur (Lower Saxony Ministry of Science and Culture).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A promising cell-therapy approach for heart failure aims at differentiating human pluripotent stem cells (hPSCs) into functional cardiomyocytes (CMs) in vitro to replace the disease-induced loss of patients' heart muscle cells in vivo. But many challenges remain for the routine clinical application of hPSC-derived CMs (hPSC-CMs), including good manufacturing practice (GMP)-compliant production strategies. This protocol describes the efficient generation of hPSC-CM aggregates in suspension culture, emphasizing process simplicity, robustness and GMP compliance. The strategy promotes clinical translation and other applications that require large numbers of CMs. Using a simple spinner-flask platform, this protocol is applicable to a broad range of users with general experience in handling hPSCs without extensive know-how in biotechnology. hPSCs are expanded in monolayer to generate the required cell numbers for process inoculation in suspension culture, followed by stirring-controlled formation of cell-only aggregates at a 300-ml scale. After 48 h at checkpoint (CP) 0, chemically defined cardiac differentiation is induced by WNT-pathway modulation through use of the glycogen-synthase kinase-3 inhibitor CHIR99021 (WNT agonist), which is replaced 24 h later by the chemical WNT-pathway inhibitor IWP-2. The exact application of the described process parameters is important to ensure process efficiency and robustness. After 10 d of differentiation (CP I), the production of ≥100 × 106 CMs is expected. Moreover, to 'uncouple' cell production from downstream applications, continuous maintenance of CM aggregates for up to 35 d in culture (CP II) is demonstrated without a reduction in CM content, supporting downstream logistics while potentially overcoming the requirement for cryopreservation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell Culture TechniquesCell DifferentiationMyocytes, CardiacPluripotent Stem CellsHumans

Autor:innen und Institutionen

  • Department of Cardiothoracic, Transplantation and Vascular Surgery (HTTG), Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO); REBIRTH-Research Center for Translational Regenerative Medicine;…
  • Evotec, Hamburg, Germany.
  • Department of Cell Therapy Process Technology, Novo Nordisk, Måløv, Denmark.

ORCID-Profile: Nils Kriedemann, Kevin Ullmann, Felix Manstein, Lika Drakhlis, Alexandra Haase, Ulrich Martin, Robert Zweigerdt

Förderung

  • Deutsche Forschungsgemeinschaft (German Research Foundation)
  • Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research)
  • Niedersächsische Ministerium für Wissenschaft und Kultur (Lower Saxony Ministry of Science and Culture)
  • European Commission (EC)
  • Niedersächsisches Ministerium für Wissenschaft und Kultur

Zitieren

APA

Kriedemann, N., Triebert, W., Teske, J., Mertens, M., Franke, A., Ullmann, K., Manstein, F., Drakhlis, L., Haase, A., Halloin, C., Martin, U., & Zweigerdt, R. (2024). Standardized production of hPSC-derived cardiomyocyte aggregates in stirred spinner flasks. Nature Protocols. https://doi.org/10.1038/s41596-024-00976-2

Vancouver

Kriedemann N, Triebert W, Teske J, Mertens M, Franke A, Ullmann K, et al. Standardized production of hPSC-derived cardiomyocyte aggregates in stirred spinner flasks. Nature Protocols. 2024. doi:10.1038/s41596-024-00976-2

BibTeX
@article{Kriedemann2024,
  author = {Kriedemann, Nils and Triebert, Wiebke and Teske, Jana and Mertens, Mira and Franke, Annika and Ullmann, Kevin and Manstein, Felix and Drakhlis, Lika and Haase, Alexandra and Halloin, Caroline and Martin, Ulrich and Zweigerdt, Robert},
  title = {Standardized production of hPSC-derived cardiomyocyte aggregates in stirred spinner flasks},
  journal = {Nature Protocols},
  year = {2024},
  doi = {10.1038/s41596-024-00976-2}
}
Kostenlos starten →